Stock CPH CIPHER PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Cipher Pharmaceuticals Inc.

Equities

CPH

CA17253X1050

Market Closed - Toronto S.E.
Other stock markets
 01:29:47 27/04/2024 am IST 		5-day change 1st Jan Change
8.5 CAD 0.00% Intraday chart for Cipher Pharmaceuticals Inc. 0.00% +53.43%
15/03 Transcript : Cipher Pharmaceuticals Inc., Q4 2023 Earnings Call, Mar 15, 2024
14/03 Tranche Update on Cipher Pharmaceuticals Inc.'s Equity Buyback Plan announced on November 15, 2023. CI

Chart calendar Cipher Pharmaceuticals Inc.

9949a0fd304ff9faa7c86dd.VvD_kHQ7cZRE5UVEkRX3GsenqhRWlosLs5EplBtSh5o.Ipa6pjgINqI2qg8H50akS73_4VsSwuhPw-BtuSJq7cIRgbH5E20Gxi6DHA~ad10de8fc0e70f81b5110008e3f5efc7

Upcoming events on Cipher Pharmaceuticals Inc.

09/05/2024 Q1 2024 Earnings Release (Projected)
14/06/2024 Annual General Meeting
08/08/2024 Q2 2024 Earnings Release (Projected)
07/11/2024 Q3 2024 Earnings Release (Projected)
13/03/2025 Q4 2024 Earnings Release (Projected)

Past events on Cipher Pharmaceuticals Inc.

18/04/2024 12:00 am Bloom Burton & Co. Healthcare Investor Conference
15/03/2024 06:00 pm Q4 2023 Earnings Call
15/03/2024 02:30 am Q4 2023 Earnings Release
10/11/2023 07:00 pm Q3 2023 Earnings Call
10/11/2023 03:30 am Q3 2023 Earnings Release
11/08/2023 06:00 pm Q2 2023 Earnings Call
11/08/2023 02:30 am Q2 2023 Earnings Release
21/06/2023 07:30 pm Annual General Meeting
12/05/2023 06:00 pm Q1 2023 Earnings Call
12/05/2023 02:47 am Q1 2023 Earnings Release
25/04/2023 08:00 pm Bloom Burton & Co Healthcare Investor Conference
17/03/2023 06:00 pm Q4 2022 Earnings Call
17/03/2023 02:30 am Q4 2022 Earnings Release
08/12/2022 01:30 am Planet MicroCap Showcase
11/11/2022 07:00 pm Q3 2022 Earnings Call
11/11/2022 05:11 am Q3 2022 Earnings Release
12/08/2022 06:00 pm Interim 2022 Earnings Call
12/08/2022 02:31 am Interim 2022 Earnings Release
22/06/2022 07:30 pm Annual General Meeting
13/05/2022 06:00 pm Q1 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million CAD		Released
Forecast
Spread 		32,2
28,8
12%		26,9
26,0
3.19%		27,7
28,0
-0.83%		28,4
28,6
-0.46%		28,6
29,5
-2.89%
28,9

EBITDA
Million CAD		Released
Forecast
Spread 		18,0
13,2
36.8%		17,0
16,1
5.37%		17,6
16,4
7.25%		17,1
16,6
2.83%		17,2
17,5
-1.7%
17,2

EBIT
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

Earnings before Tax (EBT)
Million CAD		Released
Forecast
Spread 		8,17
11,8
-30.69%		8,13
14,4
-43.43%		14,0
13,8
1.42%		15,8
15,4
2.41%		17,1
16,1
6.74%
13,8

Net income
Million CAD		Released
Forecast
Spread 		2,72
5,76
-52.74%		5,66
9,09
-37.76%		9,81
9,72
0.9%		36,6
12,2
199.3%		27,6
20,2
36.61%
12,9

EPS
CAD		Released
Forecast
Spread 		0,14
0,16
-9.78%		0,20
0,31
-36.72%		0,37
0,35
3.41%		1,42
0,47
203.66%		1,08
0,79
36.88%
0,49

Announcement Date25/03/2018/03/2117/03/2216/03/2314/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million CAD		Released
Forecast
Spread 		7,40
7,58
-2.35%		7,03
7,20
-2.3%		7,09
8,28
-14.34%		6,41
7,33
-12.55%		6,75
7,55
-10.52%		6,59
7,61
-13.44%		7,09
7,21
-1.7%		8,35
7,03
18.79%		6,65
7,25
-8.24%
6,81


7,34


7,31


7,33


7,71

EBITDA
Million CAD		Released
Forecast
Spread 		5,15
4,80
7.22%		4,03
4,17
-3.36%		4,55
4,79
-4.81%		3,52
4,50
-21.79%		4,33
4,32
0.25%		4,28
4,35
-1.71%		4,12
3,99
3.25%		4,96
3,92
26.61%		3,87
4,16
-7.01%
4,53


4,13


4,46


4,06


4,33

Earnings before Tax (EBT)
Million CAD		Released
Forecast
Spread 		4,95
4,80
3.01%





3,07
3,86
-20.53%		4,04
3,99
1.21%		3,65
3,69
-1.07%		4,25
3,09
37.26%		4,30
3,08
39.65%		4,98
3,67
35.55%














Net income
Million CAD		Released
Forecast
Spread 		3,55
3,53
0.58%





3,55
2,84
25.07%		27,1
2,93
823.71%		3,54
2,71
30.51%		4,12
2,28
80.22%		9,68
2,26
328.05%		10,3
2,70
283.56%














EPS
CAD		Released
Forecast
Spread 		0,14
0,14
0.76%





0,13
0,12
16.3%		1,06
0,12
782.48%		0,13
0,11
22.6%		0,16
0,12
32.35%		0,37
0,09
295.33%		0,41
0,13
213.13%
0,14


0,15


0,18


0,15




Announcement Date17/03/2212/05/2211/08/2210/11/2216/03/2311/05/2310/08/2309/11/2314/03/24-----

Upcoming sector events for Cipher Pharmaceuticals Inc.

29/04/2024 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q1 2024 Earnings Release (Projected)
29/04/2024 SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q4 2023 Earnings Release
29/04/2024 BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 JIANGXI FUSHINE PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 AURISCO PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
29/04/2024 PT TEMPO SCAN PACIFIC TBK: Q1 2024 Earnings Release (Projected)
29/04/2024 SICHUAN HUIYU PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
29/04/2024 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
29/04/2024 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 WEDGE INDUSTRIAL CO.,LTD.: Q1 2024 Earnings Release
More events

Past sector events for Cipher Pharmaceuticals Inc.

Today LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q4 2023 Earnings Release
Today NANJING VAZYME BIOTECH CO.,LTD: Q4 2023 Earnings Release
Today LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q1 2024 Earnings Release
Today HUNAN ER-KANG PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
Today ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
Today GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q1 2024 Earnings Release
Today GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q4 2023 Earnings Release
Today NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
Today ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
Today ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CPH Stock
  4. Calendar Cipher Pharmaceuticals Inc.